focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 12,168.00
Ask: 12,170.00
Change: -74.00 (-0.60%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks rise as upbeat forecast from Volkswagen spurs rally in autos

Tue, 16th Mar 2021 09:23

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* European autos sector touches highest level since June
2018

* Zalando at 3-week peak, retail sector hits record high

* Volkswagen says cost cuts to boost margin, shares jump

* European stocks volatility gauge at February 2020 lows
(Adds analyst comments, updates prices throughout)

By Shreyashi Sanyal

March 16 (Reuters) - European stocks rose on Tuesday as an
upbeat forecast from German carmaker Volkswagen prompted a rally
in the automobiles sector, while investors awaited the U.S.
Federal Reserve's views on a recent pickup in inflation.

The pan-European STOXX 600 index rose 0.9%, inching
closer to a record peak set last year, while the regional autos
sector jumped 2.1% to its highest level since June 2018.

Leading gains among autos was Volkswagen AG
which jumped 6.7% after it said it was confident that cost cuts
will help improve profit margins in the coming years.

"There is something to do with more interest as global
investors are becoming more attracted to areas outside of
technology which would include sectors like autos, mining and
industrials," said Chris Bailey, European strategist at Raymond
James.

"Particularly for autos it is a combination of higher demand
as economies recover and also these are companies with proper
international businesses."

Zalando rose 5.0% after it forecast 2021 revenue
growth above market expectations following a strong start to the
year. Its shares touched a three-week high and lifted the wider
retail index.

A gauge of volatility in European stock markets
slipped to its lowest level in over one year.

Investors are focused on the Fed's two-day policy meeting,
which will end on Wednesday amid concerns that a potential spike
in inflation as economies recover could prompt the central bank
to tighten monetary policy sooner than expected.

Official data showed French final inflation rose largely in
line with estimates in February. Meanwhile, the ZEW economic
research institute said investor sentiment in Germany increased
by more than expected in March, buoying the outlook for a
broad-based recovery in Europe's largest economy.

While optimism about an economic recovery has pushed markets
to near-record highs, concerns remain about the pace of COVID-19
vaccination in Europe, with Sweden becoming the latest country
to pause AstraZeneca's vaccine after several countries
reported possible serious side-effects.

Deutsche Bank slashed 2021 economic growth forecasts for the
euro area by a percentage point, citing spillover of the ongoing
pandemic-linked activity curbs, but raised predictions for
Britain, the United States and India.

French telecoms operator Iliad SA jumped almost
4.5% after saying it aimed to turn a core profit for its Italian
business in the second half of this year.

German biotech firm Morphosys slumped
10.6????????% to the bottom of STOXX 600 after forecasting a
fall in 2021 revenue.
(Reporting by Sruthi Shankar and Devik Jain in Bengaluru
Editing by Arun Koyyur and Matthew Lewis)

More News
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.